Cargando…

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease

AIMS: To ascertain the tolerability profile of single and repeated oral doses of methanesulfonyl fluoride (MSF, SNX-001) in healthy aged subjects, and to determine the degree of erythrocyte acetylcholinesterase (AChE) inhibition induced by MSF after single and repeated oral doses. METHODS: To calcul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moss, Donald E, Fariello, Ruggero G, Sahlmann, Jörg, Sumaya, Isabel, Pericle, Federica, Braglia, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Science Inc 2013
Materias:	Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635594/ https://www.ncbi.nlm.nih.gov/pubmed/23116458 http://dx.doi.org/10.1111/bcp.12018

Ejemplares similares

Irreversible electroporation on the small intestine
por: Phillips, M A, et al.
Publicado: (2012)

1-Methanesulfonyl-1H-1,2,3-benzotriazole
por: Štěpnička, Petr, et al.
Publicado: (2010)

Synthesis and Elimination Pathways of 1-Methanesulfonyl-1,2-dihydroquinoline Sulfonamides
por: Ametsetor, Ebenezer, et al.
Publicado: (2023)

Development of novel N-(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer's disease
por: Mishra, Chandra Bhushan, et al.
Publicado: (2020)

Post-Synthetic Derivatization of Graphitic Carbon Nitride with Methanesulfonyl Chloride: Synthesis, Characterization and Photocatalysis
por: Praus, Petr, et al.
Publicado: (2020)

Cholinesterase inhibitors as Alzheimer's therapeutics
por: Sharma, Kamlesh
Publicado: (2019)

Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Are Irreversible Inhibitors the Future?
por: Moss, Donald E.
Publicado: (2020)

Crystal structure of 1-methanesulfonyl-1,2,3,4-tetrahydroquinoline
por: Jeyaseelan, S., et al.
Publicado: (2015)

Crystal structure of 1-bromo-4-methanesulfonyl-2,3-dimethylbenzene
por: Dai, Shangwei, et al.
Publicado: (2015)

Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
por: Ioannou, N, et al.
Publicado: (2011)

Determinants of acute irreversible electroporation lesion characteristics after pulsed field ablation: the role of voltage, contact, and adipose interference
por: Gasperetti, Alessio, et al.
Publicado: (2023)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

Ultrasound-Assisted Synthesis and In Silico Modeling of Methanesulfonyl-Piperazine-Based Dithiocarbamates as Potential Anticancer, Thrombolytic, and Hemolytic Structural Motifs
por: Hafeez, Freeha, et al.
Publicado: (2022)

Response to cholinesterase inhibitors affects lifespan in Alzheimer’s disease
por: Wattmo, Carina, et al.
Publicado: (2014)

The Reactions of 6-(Hydroxymethyl)-2,2-dimethyl-1-azaspiro[4.4]nonanes with Methanesulfonyl Chloride or PPh(3)-CBr(4)
por: Khoroshunova, Yulia V., et al.
Publicado: (2021)

Alzheimer's disease and Type 2 diabetes mellitus: the cholinesterase connection?
por: Allam, Appa Rao, et al.
Publicado: (2006)

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
por: Parsons, Chris G., et al.
Publicado: (2013)

CHRNA7 Polymorphisms and Response to Cholinesterase Inhibitors in Alzheimer's Disease
por: Weng, Pei-Hsuan, et al.
Publicado: (2013)

Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease
por: Hussein, Weiam, et al.
Publicado: (2018)

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease
por: Motter, Jeffrey N., et al.
Publicado: (2021)

Irreversibility in dynamical phases and transitions
por: Seara, Daniel S., et al.
Publicado: (2021)

Ewald Hering’s (1899) On the Limits of Visual Acuity: A Translation and Commentary: With a Supplement on Alfred Volkmann’s (1863) Physiological Investigations in the Field of Optics
por: Strasburger, Hans, et al.
Publicado: (2018)

Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer’s Disease
por: Schino, Ignazio, et al.
Publicado: (2022)

Cholinesterase Research
por: Korabecny, Jan, et al.
Publicado: (2021)

Quaternary Ammonium Salt Strategy and Molecular Docking Studies of Novel 5-Acyl-8-(Arylamino)-Quinolines by Acetyl and Methanesulfonyl Chloride for Dual Evaluation Bioactivity
por: Feng Jin, et al.
Publicado: (2023)

Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma
por: Woeste, Matthew R, et al.
Publicado: (2023)

Mechanism-based treatments for Alzheimer's disease
por: Davies, Peter, et al.
Publicado: (2009)

A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease
por: S. Schneider, Lon
Publicado: (2000)

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
por: Rountree, Susan D, et al.
Publicado: (2009)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
por: Farrimond, Lucy E, et al.
Publicado: (2012)

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort
por: Wattmo, Carina, et al.
Publicado: (2012)

Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer's disease
por: Khan, Mohd. Babu, et al.
Publicado: (2018)

Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease
por: Amat-ur-Rasool, Hafsa, et al.
Publicado: (2021)

Effect of QT Prolongation in Patients Taking Cholinesterase Inhibitors (Donepezil) for Alzheimer’s Disease
por: Kuwahata, So, et al.
Publicado: (2021)

Development of substituted benzylidene derivatives as novel dual cholinesterase inhibitors for Alzheimer's treatment
por: Gupta, Shraddha Manish, et al.
Publicado: (2023)

Early detection of Alzheimer's disease: new diagnostic criteria
por: Dubois, Bruno, et al.
Publicado: (2009)

Novel strategies for the prevention of dementia from Alzheimer's disease
por: Shineman, Diana W., et al.
Publicado: (2009)

The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
por: Millan, Mark J.
Publicado: (2014)

QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy
por: Ramos, Eva, et al.
Publicado: (2019)

Biological markers for early detection and pharmacological treatment of Alzheimer's disease
por: Hampel, Harald, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_cccv9h90ksor05jti9g5fu1t4l